It has been hypothesized that the absence of response to anti-PD-1 monotherapy in CLL could be due to the elevated expression of several inhibitory checkpoints on pseudo-exhausted T cells [54]. This evidence concerns the gene PDCD1 and B-cell chronic lymphocytic leukemia.